NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | 24.30% |
| Q3 2025 | -5.45% |
| Q2 2025 | -21.72% |
| Q1 2025 | 28.87% |
| Q4 2024 | 5.26% |
| Q3 2024 | -6.78% |
| Q2 2024 | -6.19% |
| Q1 2024 | -14.14% |
| Q4 2023 | -16.64% |
| Q3 2023 | -5.93% |
| Q2 2023 | 10.85% |
| Q1 2023 | 9.13% |
| Q4 2022 | 8.71% |
| Q3 2022 | 17.37% |
| Q2 2022 | 1.66% |
| Q1 2022 | 13.67% |
| Q4 2021 | 5.17% |
| Q3 2021 | 11.89% |
| Q2 2021 | -16.67% |
| Q1 2021 | 15.77% |
| Q4 2020 | 19.04% |
| Q3 2020 | 75.49% |
| Q2 2020 | 30.71% |
| Q1 2020 | -31.83% |
| Q4 2019 | 8.87% |
| Q3 2019 | 9.02% |
| Q2 2019 | -3.10% |
| Q1 2019 | 108.59% |
| Q4 2018 | -45.60% |
| Q3 2018 | 70.49% |
| Q2 2018 | 114.70% |
| Q1 2018 | -55.29% |
| Q4 2017 | -13.52% |
| Q3 2017 | 73.34% |
| Q2 2017 | 117.54% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |